Related Experiment Video
Updated: Feb 1, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
HDACi induces apoptosis of osteosarcoma cells by inhibiting the MAPK pathway
Chao Qin1, Tao-Tao Lin1, Yi-Min Lin1
1Department of orthopedics, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, P. R. China.
Abstract:
Investigate the malignant biological effects of the histone deacetylase inhibitor (HDACi) in osteosarcoma (OS) and study the underlying mechanisms through mRNA sequencing. CCK-8, colony formation, Transwell assays, live/dead staining, and flow cytometry were used to observe the malignant biological effects of 4-phenylbutyric acid (4-PA) on OS cells. mRNA sequencing revealed the mechanism of action of 4-PA on OS cells. Western blotting (WB) was used to detect changes in the expression of histone acetylation, apoptosis, and MAPK-related proteins in OS cells treated with 4-PA. Flow cytometry was used to examine the number of apoptotic OS cells after 4-PA intervention. Animal experiments were conducted to validate the effects of 4-PA on OS cells in vivo. Intervention with 4-PA can significantly inhibit the activity, invasion, migration, and colony-forming abilities of OS cells, while promoting cell death and cell cycle arrest. Results from flow cytometry and apoptosis-related protein detection suggest that 4-PA has the ability to induce apoptosis in OS cells. mRNA sequencing and Western blot analyses showed that 4-PA can inhibit the MAPK/ERK pathway in OS cells. Rescue experiments indicated that the promotion of apoptosis in OS cells by 4-PA may be achieved through the inhibition of the MAPK/ERK pathway. In vivo experiments further confirmed the inhibitory effect of 4-PA on OS growth and its ability to promote apoptosis. The results suggest that HDACi can significantly inhibit the malignant biological abilities of OS cells and induce apoptosis in OS cells by suppressing the MAPK/ERK pathway.
Insights
4-phenylbutyric acid (4-PA), a histone deacetylase inhibitor (HDACi), significantly inhibits osteosarcoma (OS) cell growth and induces apoptosis. This occurs by suppressing the MAPK/ERK pathway, offering a potential therapeutic strategy for OS.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) is a primary bone malignancy with limited effective treatments.
- Histone deacetylase inhibitors (HDACi) show potential anti-cancer properties.
- Understanding the molecular mechanisms of HDACi in OS is crucial for therapeutic development.
Purpose of the Study:
- To investigate the anti-cancer effects of 4-phenylbutyric acid (4-PA), an HDACi, on osteosarcoma (OS) cells.
- To elucidate the underlying molecular mechanisms, particularly the involvement of the MAPK/ERK pathway.
- To evaluate the in vivo efficacy of 4-PA in an OS animal model.
Main Methods:
- Cell viability, invasion, migration, and colony formation assays were performed.
- Apoptosis and cell cycle progression were analyzed using flow cytometry.
- mRNA sequencing and Western blotting were employed to study molecular changes.
- In vivo experiments in animal models validated the findings.
Main Results:
- 4-PA significantly inhibited OS cell proliferation, invasion, migration, and colony formation.
- 4-PA induced significant apoptosis and cell cycle arrest in OS cells.
- mRNA sequencing and Western blot revealed 4-PA suppresses the MAPK/ERK pathway.
- In vivo studies confirmed 4-PA's inhibitory effect on OS tumor growth and its pro-apoptotic action.
Conclusions:
- 4-PA effectively suppresses malignant biological behaviors of OS cells.
- 4-PA induces apoptosis in OS cells, partly through the inhibition of the MAPK/ERK pathway.
- HDACi, like 4-PA, represents a promising therapeutic avenue for osteosarcoma.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Related Concept Videos
Feedback Inhibition
MAPK Signaling Cascades
Apoptosis
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Enzyme Inhibition
Induced Pluripotent Stem Cells